Reversing aging is often framed like hitting a reset button on a digital clock, but for those of us staring down a microscope at satellite cell exhaustion, the reality’s far more visceral. If we successfully roll back the epigenetic marks in a 90-year-old myofiber but fail to restore the Notch-dependent signaling that allows that fiber to actually repair itself, we haven’t achieved much. We’ve just created a cellular ghost.

There’s a steep price to any "successful" intervention that extends lifespan without restoring kinetic agency. Aging isn’t just the accumulation of damage; it’s a slow, agonizing narrowing of what a human being is actually capable of doing. When we optimize for "reduced all-cause mortality," we’re effectively measuring how long we can keep the lights on in an empty house. It isn't a victory to be 100 years old with the "biological age" of a 40-year-old on paper while remaining trapped in a musculoskeletal system that’s lost its mechanical reserve.

If aging is truly reversible, the stake isn’t just "not dying." It’s the re-acquisition of the self. The self is defined by movement, by the ability to interact with the world, and by the cellular "memory" of how to heal. If we ignore structural decay—Dll1 loss, cross-linked collagen, niche fibrosis—in favor of easy-to-measure metabolic markers, we’re just industrializing the waiting room.

The "survival" paradigm needs to go. Funding and collaboration should shift toward functional regeneration—restoring the gatekeepers of the nuclear pore, the rheostats of atrogene expression, and the ligands that tell a dormant cell it’s time to build again. We aren’t just trying to live longer; we’re trying to stay biologically relevant to our own lives. Anything less isn’t a cure. It’s a longer sentence. If we’re going to argue for the moral necessity of longevity, we have to ensure we aren’t just perfecting the art of the slow collapse.